SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sandu Pharmaceutical - Quaterly Results

05 Jun 2024 Evaluate
The company's total revenue for the quarter ended March 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 155.98 millions.Net Profit for the quarter ended March 2024 zoomed to 116.42% from Rs. 2.74 millions to Rs. 5.93  millions.Operating Profit saw a handsome growth to 9.10 millions from 5.28 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 155.98 152.65 2.18 672.81 653.49 2.96 672.81 653.49 2.96
Other Income 3.07 0.45 582.22 4.21 3.27 28.75 4.21 3.27 28.75
PBIDT 9.10 5.28 72.35 27.18 28.16 -3.48 27.18 28.16 -3.48
Interest 0.07 0.16 -56.25 0.63 0.80 -21.25 0.63 0.80 -21.25
PBDT 9.03 5.12 76.37 26.55 27.36 -2.96 26.55 27.36 -2.96
Depreciation 1.86 1.34 38.81 5.83 5.17 12.77 5.83 5.17 12.77
PBT 7.17 3.78 89.68 20.72 22.19 -6.62 20.72 22.19 -6.62
TAX 1.24 1.04 19.23 6.12 6.96 -12.07 6.12 6.96 -12.07
Deferred Tax -0.86 0.03 -2966.67 0.25 0.34 -26.47 0.25 0.34 -26.47
PAT 5.93 2.74 116.42 14.60 15.23 -4.14 14.60 15.23 -4.14
Equity 96.61 96.61 0.00 96.61 96.61 0.00 96.61 96.61 0.00
PBIDTM(%) 5.83 3.46 68.67 4.04 4.31 -6.25 4.04 4.31 -6.25

Sandu Pharmaceutical Share Price

38.45 0.50 (1.32%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×